Technological features added to NeVA to increase linguistic inclusiveness (See 'Corp Brief') IBC - Entries in balance sheets can qualify as acknowledgments u/s 18 of Limitation Act, even if creditor is not explicitly named: SC (See 'Legal Desk') Miscellaneous - Negotiable Instruments Act - while Section 348 of BNSS grants wide powers to summon or recall witnesses in the interest of justice, yet it cannot be used to fill lacunae in evidence or prolong proceedings unnecessarily: HC (See 'Legal Desk') BSNL Subscriber Base grows to 9.1 Crore (See 'Corp Brief') IPR - Distinctiveness of combination mark cannot be negated by dissecting such mark: HC (See 'Legal Desk') IBC - If lease amount is unpaid by Corporate Debtor, it amounts to Operational Debt: NCLT (See 'Legal Desk') CCI okays combination of Anantam Highways Trust & Alpha Alternatives Fund (See 'Corp Brief') IPR - Fact that existing competitor in comparison to new entrant in market has deliberately, intentionally and in calculated manner attempted to reap from cultivated soil of trade rival, is impermissible: HC (See 'Legal Desk') With 24 Countries Onboard, India leads in Global Big Cat Protection (See 'Corp Brief') PMLA - 'Predicate offences' lodged under newly introduced Bharatiya Nyaya Sanhita can be treated as 'scheduled offences' under stringent PMLA, even if its schedule only refers to repealed IPC: HC (See 'Legal Desk') CCI approves acquisition of equity of Renault Nissan Automotive by Renault Group B.V. and Renault S.A.S. (See 'Corp Brief') NI Act - Debt arising from illegal cash transaction in violation of Income Tax Act is not legally enforceable debt: HC (See 'Legal Desk') Ministry of Ayush advances Scientific Research through AYURGYAN Scheme (See 'Corp Brief') A&C - Foreign arbitral award cannot be enforced against person who was not party to arbitration proceedings: HC (See 'Legal Desk') Scindia announces launch of Sanchar Saathi Mobile App in Hindi & 21 regional languages (See 'Corp Brief') IPR - Company that suffers loss/damages due to acts of accused for selling counterfeit products can file appeal against acquittal as 'victim' under proviso to Sec 372 CrPC: SC (See 'Legal Desk') NI Act - Amendment to complaint u/s 138 can be made at post-cognizance stage, provided that no 'prejudice' is caused to accused and complainant's cross-examination is awaited: SC (See 'Legal Desk') Scindia reviews BSNL's Performance, Emphasizes Customer Experience (See 'Corp Brief') PMLA - Being secured mortgagee, bank is at liberty to stake its claim before PMLA Court u/s 8(5), with notice to other secured and unsecured creditors: SAFEMA (See 'Legal Desk') Govt ensures better use of LPG by PMUY beneficiaries: MoS (See 'Corp Brief') Competition Act - Information filed beyond statutory 3 year period cannot be condoned where no cogent reasoning is provided therefor; conduct of respondent also not found to be in abuse of dominant position or an anti-competitive agreement: CCI (See 'Legal Desk') Earth Sciences Ministry's Foundation Day: MoS announces 14 scientific products (See 'Corp Brief') SEBI - SECC Regulations - penal provisions must be interpreted strictly, especially when civil liabilities and penalties are involved: SAT (See 'Legal Desk') J&K witnesses Rapid Upgradation of Rail Tracks and Coaches (See 'Corp Brief') Stronger the Logistics, Stronger the Borders: Rajnath Singh (See 'Corp Brief') IPR - Indiamart shall be restrained from providing registered trademark 'PUMA' in respect of goods if search options in its drop down menu presented to prospective sellers at time of registration on e-commerce platform: HC (See 'Legal Desk') APEDA refutes unfounded allegations in Organic Cotton Certification (See 'Corp Brief') IPR - Sole intention of defendants was to defraud Indian consumers into mistakenly believing that it were genuine sites of Gameskraft; Rogue websites shall be restrained: HC (See 'Legal Desk') Coal Ministry holds Workshop on Exploration Module of SWCS (See 'Corp Brief') IPR - Since there is no prima facie sustainable allegation of involvement, by Amazon Tech, in any infringement of Lifestyle's registered trademark, does not amount to deliberate infringment: HC (See 'Legal Desk') Re-thinking Royalty in the Digital Age (See CORP EINSICHT)

Ministry of Ayush advances Scientific Research through AYURGYAN Scheme

Published: Jul 30, 2025

By TIOLCorplaws News Service

NEW DELHI, JULY 30, 2025: THE Government has taken following steps for the qualitative production and distribution of Ayush medicines:

1. The Drugs and Cosmetics Act, 1940 & rules made thereunder have exclusive regulatory provisions regarding manufacture for sale or for distribution of Ayurvedic, Siddha, Sowa- Rigpa, Unani, and Homoeopathy drugs. It is mandatory for the manufacturers to adhere to the prescribed requirements for licensing of manufacturing units & medicines including proof of safety & effectiveness, compliance with the Good Manufacturing Practices (GMP) as per Schedule T & Schedule M-I of Drugs Rules, 1945 and quality standards of drugs given in the respective pharmacopoeia.

2. Rule 160 A to J of the Drugs Rules, 1945 provides the regulatory guidelines for approval of Drug Testing Laboratories for carrying out such tests of identity, purity, quality and strength of Ayurvedic, Siddha and Unani drugs as may be required under the provisions of these rules, on behalf of licensee for manufacture of Ayurvedic, Siddha and Unani drugs.

3. Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) on behalf of Ministry of Ayush lays down the Formulary specifications and Pharmacopoeial Standards for Ayurveda, Siddha, Unani and Homoeopathic drugs, which serves as an official compendia for ascertaining the Quality Control (identity, purity and strength) of Ayush drugs, as per the Drugs & Cosmetics Act, 1940 & rules made thereunder. Compliance to these quality standards are mandatory for Ayush drugs being manufactured in India.

4. Pharmacovigilance Centres for Ayurveda, Siddha, Unani and Homoeopathic drugs set up in different parts of the country under the Central Sector Scheme of Ministry of Ayush are mandated to report adverse drug reactions to the respective State Regulatory Authorities.

5. Central Sector Scheme, Ayush Oushadhi Gunavatta evam Uttpadan Samvardhan Yojana (AOGUSY) has been implemented for the year 2021-2026. One of the components of this Scheme is to strengthen and up-grade Ayush Pharmacies and Drug Testing Laboratories to achieve higher standards.

6. An Ayush vertical has been created in Central Drugs Standard Control Organization (CDSCO) to strengthen regulatory measures ensuring safety and quality of Ayush drugs. Further, CDSCO issues WHO Certificate of Pharmaceutical Product (WHO-CoPP) to Ayush drugs having compliance to such standards.

7. Quality Certifications Scheme implemented by the Quality Council of India (QCI) for grant of Ayush mark to Ayurvedic, Siddha and Unani products on the basis of third party evaluation of quality in accordance with the status of compliance to domestic and international standards.

Further, Government has taken following steps for widening and deepening research in Ayush medicines:

1. The Ministry of Ayush is implementing the Central Sector Scheme namely AYURGYAN Scheme from FY 2021-22. The Scheme has 03 components viz. (i) Capacity Building & Continuing Medical Education (CME) in Ayush (ii) Research & Innovation in Ayush and (iii) Ayurveda Biology Integrated Health Research added under the scheme from FY 2023-24. Under the Research & Innovation in Ayush component, financial assistance is provided to the eligible Organizations/Institutions across the county as per the provision contained in the scheme guidelines to support clinical, fundamental, pharmaceutical, literary and medicinal plant research in Extra Mural mode.

2. Government of India has established Central Council for Research in Ayurvedic Sciences (CCRAS), Central Council for Research in Unani Medicine (CCRUM), Central Council for Research in Homoeopathy (CCRH), Central Council for Research in Siddha (CCRS) and Central Council for Research in Yoga & Naturopathy (CCRYN) under the Ministry of Ayush as apex organizations for undertaking, coordinating, formulating, developing and promoting research in Ayush system on scientific lines. Core research activities comprise of Medicinal Plant Research (Medico-Ethno Botanical Survey), Pharmacognosy and in-vitro propagation techniques, Drug Standardization, Pharmacological Research, Clinical Research, Literary Research and Documentation and Tribal Health Care Research Programme.

Ministry of Ayush has implemented Central Sector Scheme for promotion of Information Education and Communication (IEC) in Ayush to create awareness regarding Ayush Systems of Medicine. This aims to reach out to all sections of the population across the country. This scheme provides assistance for organizing National/State Arogya Fairs, Yoga Fests/Utsavs, Ayurveda Parvs etc. The Ministry also undertakes Multi-Media, Print Media Campaigns for creating awareness about Ayush systems.

CCRAS, CCRUM, CCRH, CCRS and CCRYN are the apex organizations established under the Ministry of Ayush for undertaking, coordinating, formulating, developing and promoting research in Ayush system on scientific lines. The Councils are also engaged in awareness activities for the promotion of Ayush systems through IEC activities and through electronic and print media for common people in English, Hindi, and regional languages, which are widely distributed through National/ State level Arogya health melas, health camps, exhibitions, expos and outreach programs.

Ministry of Ayush has taken initiative for inclusion of 'Traditional Medicine' chapter in the International Classification of Disease (ICD-10 and 11) supporting the scientific research, Ayush Export Promotion Council (AYUSHEXCIL), WHO Global Traditional Medicine Centre (GTMC) and celebration of Yoga and Ayurveda day etc. worldwide.

In addition, the Ministry of Ayush has taken the following steps towards international promotion, development and recognition for Ayush systems of medicine:

1. Signed 25 Country to Country MoUs for Co-operation in field of Traditional Medicine and Homoeopathy with foreign nations.

2. Signed 15 MoUs with International Institutes for setting up of Ayush Academic Chairs in foreign nations.

3. 51 Institute to Institute level MoUs with foreign institutes for undertaking Collaborative Research/Academic collaboration.

4. Supported the establishment of 43 Ayush Information Cells in 39 foreign nations.

5. Offering scholarships to foreign nationals for studying Ayush courses in recognized Ayush institutions in India under International Fellowship/Scholarship Programs.

 This information was given by Union Minister of State (I/C) of the Ministry of Ayush, Prataprao Jadhav in a written reply in Rajya Sabha yesterday.

TIOL CORP SEARCH

TIOL GROUP WEBSITES